CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Profit booking emerges at higher levels; Bank Nifty plunge 500 points from days high, volatility rears its ugly head

DSIJ Intelligence-3 0 1044 Article rating: 4.7

India VIX is back in green thereby, indicating that volatility is rearing its ugly head. Going forward, the level of 14,880 can be an important level to watch out for on the index.  

Demystifying trading range

DSIJ Intelligence-3 0 1454 Article rating: 4.6

When the price is being pushed up to the higher end of the range, sellers are letting it to run-up, to see how far the price can move. If it inches higher, it would fetch more profits for the sellers when they sell into it. Hence, as the price is approaching the upper end of the range, it tends to accelerate.

Aurionpro subsidiary & Mastercard enter into strategic alliance; stock climbs almost 6 per cent

DSIJ Intelligence 0 953 Article rating: 4.5

On Wednesday, SC Soft Private Limited (Singapore), a subsidiary of Aurionpro Solutions Limited signed a strategic alliance with Mastercard to provide services in the areas of contactless ticketing for transit operators & system integrators, enabling digital fare media adaptation and implementation globally.  

Sensex rallies 700 points, Nifty reclaims 14,800 mark; broad put addition in Nifty from 14,700-14,800

DSIJ Intelligence-3 0 1058 Article rating: 4.8

On the options' front, broad put addition has been witnessed in the range of 14,700-14,800. The 14,700 put options have added nearly 37 lakh shares in the open interest in today’s session itself, while the 14,800 put option has seen the addition of 26.55 lakh shares in the open interest.

Corinth Group of Switzerland to invest USD 100 million in Morepen Laboratories

Apurva Joshi 0 1434 Article rating: 4.7

The board of directors of Morepen Laboratories Limited has approved the investment proposed by Corinth Group, a global private investment group, headquartered in Switzerland, to the extent of USD 32.50 million in the parent company, Morepen Laboratories Limited out of a total USD 100 million investment in the promoter group. 

Goldiam International rises 6 per cent on bagging export order worth Rs 70 crore

DSIJ Intelligence 0 977 Article rating: 5.0

Goldiam Group has received export orders worth Rs 70 crore from its international clients for the manufacturing of diamond-studded designed gold jewellery. The order will be delivered within the next 100 days. With this additional order, Goldiam Group's order book crosses an aggregate of Rs 150 crore as of now.

JSPL plans to divest entire stake in Jindal Power; hits 52-week high

DSIJ Intelligence 0 1137 Article rating: 4.0

Jindal Steel & Power Limited (JSPL), an industrial powerhouse of the country, informed this morning about its divestment in Jindal Power Ltd, which is a material subsidiary of the company. The company has accepted a binding offer from Worldone Private Limited (acquirer) and has divested its 96.42 per cent stake in Jindal Power Limited (JPL).

Cash flow management plays critical role when crisis hits real estate: Rohit Garodia

DSIJ Intelligence 0 1660 Article rating: 3.8

Instances of financial indiscipline are always noticed when real estate developers get over-ambitious and go on a land-buying spree, or take more projects than possible. 

Managing Partner of Pecan Reams, Rohit Garodia believes that cash flow management plays a critical role when a crisis hits real estate.   

Real estate developers encountering a cash flow management crisis is often not unheard of. A fairly common situation, it is often seen to be a fallout of expected market trends of the sale price increase and high-volume unit sales not being realised. Alarm bells are set off when developers face a situation where receipts are lesser than payments that need to be made.  

Reliance share zooms on joining hands with BP to set up second new deepwater gas field

DSIJ Intelligence 0 1482 Article rating: 3.7

Reliance Industries Limited (RIL) informed today that it has collaborated with BP, one of the world's seven oil & gas ‘supermajors’ and British multinational company to commence production from the Satellite Cluster Gas Field in block KG D6, off the east coast of India.  

Biocon Biologics and its partner Viatris get EC nod for biosimilar Bevacizumab

Apurva Joshi 0 982 Article rating: 5.0

Biocon Limited’s subsidiary Biocon Biologics Ltd has informed the bourses that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc. has received marketing authorisation approval from European Commission (EC), following the positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency. 

Natco Pharma seeks emergency nod for its COVID-19 capsules; rises over 6 per cent

Abhinav Lahoti 0 1199 Article rating: 3.8

The company today announced that it has applied to Central Drugs Standard Control Organisation (CDSCO) of India for the approval of phase 3 clinical trials of ‘Molnupiravir’ capsules, which have shown promising results during the treatment of COVID-19 positive patient. 

In conversation with Mahesh Patil, Chief Investment Officer of Aditya Birla Sun Life AMC Ltd

DSIJ Intelligence 0 1316 Article rating: 3.7

We follow a ‘growth at a reasonable price (GARP) investing style’ since it combines the best of both worlds. We have identified themes that provide secular growth opportunities such as private banks, unorganised to organised, speciality chemicals, manufacturing in India, and technology/digital.

Alembic Pharma gets US regulator nod for Doxepin Hydrochloride capsules

DSIJ Intelligence 0 849 Article rating: 5.0

On Friday, Alembic Pharmaceuticals informed the exchanges that it has received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Doxepin Hydrochloride capsules, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg & 100 mg.  

Gland Pharma climbs nearly 2 per cent on getting USFDA nod for generic Foscarnet Sodium injection

DSIJ Intelligence 0 802 Article rating: 5.0

Gland Pharma Limited announced after the market hours on Thursday that it has received approval from United States Food & Drug Administration (USFDA) for generic Foscarnet Sodium injection, 6,000 mg/250 ml (24 mg/ml) single-dose bag for infusion.

Caplin Point rises after its subsidiary gets USFDA nod for generic version of Bloxiverz injection

DSIJ Intelligence 0 862 Article rating: 4.0

On Thursday, Caplin Point Laboratories announced that its subsidiary, Caplin Steriles Limited has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Neostigmine Methylsulfate injection.   

Betting On Bigger Homes

Ninad Ramdasi 0 620 Article rating: No rating

Given the change in scenario with work-from-home becoming a feasible option, both the salaried and entrepreneurial class of people are now looking at homes with extended space, says Santhosh Kumar, Vice Chairman, Anarock Property Consultants

Query Board

Ninad Ramdasi 0 539 Article rating: No rating

This section gives decisive investment rationales to our subscribers on the stock queries they have raised to our research team.

Vaishali Pharma climbs nearly 5 per cent on receiving supply orders worth Rs 2.02 crore

DSIJ Intelligence 0 798 Article rating: 4.3

Vaishali Pharma Limited, a pharmaceutical company based in Mumbai, announced this morning that it has bagged an order worth Rs 2.02 crore from Afghanistan.  

As per the deal, the company will engage in the supply of active pharmaceutical ingredients (API), packaging material like capsules, glass vials, rubber stoppers, flip-off seals, and sterile water for injection, etc. It will also provide specific machinery setups such as tablet manufacturing machines.

L&T Construction bags contract to build one of worlds largest oil & gas supply bases in Saudi Arabia

Apurva Joshi 0 928 Article rating: 4.7

The buildings & factories business of Larsen & Toubro Construction has secured a significant contract from Oilfields Supply Company in Saudi, owned by Dubai-based Oilfields Supply Center Ltd to design and build one of the world's largest oil & gas supply bases at King Salman Energy Park, Dammam (Kingdom of Saudi Arabia). 

Reviews

Ninad Ramdasi 0 679 Article rating: No rating

In this edition, we have reviewed Hindustan Unilever Ltd. and J B Chemicals and Pharmaceuticals Ltd. We suggest our reader-investors to HOLD in Hindustan Unilever Ltd. and J B Chemicals and Pharmaceuticals

Kerbside

Ninad Ramdasi 0 729 Article rating: No rating

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

7 Stocks for Your Portfolio

Ninad Ramdasi 0 1684 Article rating: No rating

FY 2021 has been a phenomenal year for equity as an asset class. The question is whether FY 2022 will build on the gains of FY 2021 or will the markets shed some of the weight? Yogesh Supekar discusses in detail how FY 2021 has panned out while the DSIJ Research Team shares their top seven picks to enlighten investors’ portfolio

Policy Analysis

Ninad Ramdasi 0 606 Article rating: No rating

If we purely look from a cost to benefit prespective, then it makes complete sense to invest in normal health insurance policy rather than corona rakshak or corona kavach policy.

Performance Matters

Ninad Ramdasi 0 697 Article rating: No rating

When the markets went into a slump last year on account of the pandemic, we used our experience of many years to cherry-pick mutual funds that investors would do well to choose for their portfolio.

MF Query Board

Ninad Ramdasi 0 609 Article rating: No rating

Readers are requested to send only one query at a time so that more readers get a chance. Have questions relating to any aspect of personal finance. Ask DSIJ at editorial@DSIJ.in and get your queries resolved.

Do Government Policies Impact Stock Markets?

Ninad Ramdasi 0 508 Article rating: No rating

There are very many variables that impact stock prices. However, the government fiscal policy which is announced in the annual budget every year and the monetary policy announced by the Reserve Bank of India have a special significance not only on overall economic growth and stability but also on the equity prices. Geyatee Deshpande analyses the connection and impact of both these policies on the equity prices

Understanding The ‘Price-To-Earning Parameter

Ninad Ramdasi 0 563 Article rating: No rating

Equity valuations, it is said, is the key to understanding the equity markets. Valuation is also one of the most confusing aspects of the equity market game. Shreya Chaware focuses on a group of stocks where the PE expansion was most visible. She also discusses at length why certain stocks always manage to fetch a premium over the other players in the same industry

RSS
First298299300301303305306307Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR